Login / Signup

Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE.

Roy M FleischmannRicardo BlancoFilip E Van den BoschLouis BessetteYanna SongSara K PennErin McDearmon-BlondellNasser KhanKelly ChanEduardo Mysler
Published in: Rheumatology and therapy (2024)
NCT02629159.
Keyphrases
  • rheumatoid arthritis
  • electronic health record
  • juvenile idiopathic arthritis
  • big data
  • hidradenitis suppurativa
  • data analysis